Hippo Dx
MedTech startup that has developed an allergy testing device that is faster, cheaper, and more accurate
Hippo Dx has raised €4.4M across 1 funding round from 2 investors, most recently a round in Oct 2023. Based in Brussels, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Brussels, Belgiumwww.hippo-dx.com ↗
Total raised
€4.4M
€4,400,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-10
latest 2023-10
Funding by year
EUR raised per yearHippo Dx — funding by year — interactive chart.
Data table
| Hippo Dx — funding by year | |
|---|---|
| 2023 | €4.4M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-04 | Other | €4.4M | American Allerfund Ventures,LRM | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData